Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
2.340
+0.030 (1.30%)
Dec 20, 2024, 4:00 PM EST - Market closed
Dogwood Therapeutics Statistics
Total Valuation
DWTX has a market cap or net worth of $3.12 million. The enterprise value is $1.08 million.
Market Cap | 3.12M |
Enterprise Value | 1.08M |
Important Dates
The next estimated earnings date is Friday, February 14, 2025, before market open.
Earnings Date | Feb 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
DWTX has 1.33 million shares outstanding. The number of shares has increased by 20.17% in one year.
Current Share Class | 1.33M |
Shares Outstanding | 1.33M |
Shares Change (YoY) | +20.17% |
Shares Change (QoQ) | +21.21% |
Owned by Insiders (%) | 5.62% |
Owned by Institutions (%) | 3.20% |
Float | 1.25M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 2.74 |
P/TBV Ratio | 3.28 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71
Current Ratio | 1.71 |
Quick Ratio | 1.53 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -200.48% and return on invested capital (ROIC) is -127.45%.
Return on Equity (ROE) | -200.48% |
Return on Assets (ROA) | -96.64% |
Return on Capital (ROIC) | -127.45% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.43M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.90% in the last 52 weeks. The beta is 1.33, so DWTX's price volatility has been higher than the market average.
Beta (5Y) | 1.33 |
52-Week Price Change | -84.90% |
50-Day Moving Average | 3.33 |
200-Day Moving Average | 6.07 |
Relative Strength Index (RSI) | 41.03 |
Average Volume (20 Days) | 24,987 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -5.82M |
Pretax Income | n/a |
Net Income | -5.73M |
EBITDA | n/a |
EBIT | -5.82M |
Earnings Per Share (EPS) | -$6.42 |
Balance Sheet
Cash & Cash Equivalents | 2.04M |
Total Debt | n/a |
Net Cash | 2.04M |
Net Cash Per Share | $1.53 |
Equity (Book Value) | 949,431 |
Book Value Per Share | 0.86 |
Working Capital | 949,431 |
Cash Flow
Operating Cash Flow | -4.13M |
Capital Expenditures | n/a |
Free Cash Flow | -4.13M |
FCF Per Share | -$3.10 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
DWTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.17% |
Shareholder Yield | -20.17% |
Earnings Yield | -183.65% |
FCF Yield | -132.44% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 9, 2024. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Oct 9, 2024 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |